Bevacizab 100 Mg Injection

Bevacizab 100mg Injection is a targeted therapy used in the treatment of various types of cancer. Its active ingredient, Bevacizumab, is a recombinant humanized monoclonal antibody that works by inhibiting vascular endothelial growth factor (VEGF). VEGF is a protein that stimulates the growth of new blood vessels, which tumors need to grow and spread. By blocking VEGF, Bevacizab helps to slow down or stop tumor growth and can prevent metastasis. It is commonly used in combination with chemotherapy for conditions such as metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, and metastatic renal cell carcinoma. The typical dosage and administration schedule are determined by the treating physician based on the specific cancer type, stage, and patient’s overall health. Common side effects may include high blood pressure, protein in the urine, nosebleeds, and fatigue. Less common but serious side effects can involve bleeding events, wound healing complications, and gastrointestinal perforation. Bevacizab 100mg Injection should be stored at room temperature, protected from light, and should not be frozen. Always follow your doctor’s instructions carefully when using this medication.